Literature DB >> 16159963

The LIGHT and DARC sides of herpesvirus entry mediator.

Tania H Watts1, Jennifer L Gommerman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16159963      PMCID： PMC1224668          DOI： 10.1073/pnas.0506707102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  16 in total

1.  Herpes simplex virus glycoprotein D bound to the human receptor HveA.

Authors:  A Carfí; S H Willis; J C Whitbeck; C Krummenacher; G H Cohen; R J Eisenberg; D C Wiley
Journal:  Mol Cell       Date:  2001-07       Impact factor: 17.970

2.  Cutting edge: a novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus.

Authors:  C A Benedict; K D Butrovich; N S Lurain; J Corbeil; I Rooney; P Schneider; J Tschopp; C F Ware
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

3.  Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway.

Authors:  Timothy C Cheung; Ian R Humphreys; Karen G Potter; Paula S Norris; Heather M Shumway; Bonnie R Tran; Ginelle Patterson; Rochelle Jean-Jacques; Miri Yoon; Patricia G Spear; Kenneth M Murphy; Nell S Lurain; Chris A Benedict; Carl F Ware
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-30       Impact factor: 11.205

4.  Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family.

Authors:  R I Montgomery; M S Warner; B J Lum; P G Spear
Journal:  Cell       Date:  1996-11-01       Impact factor: 41.582

5.  LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator.

Authors:  D N Mauri; R Ebner; R I Montgomery; K D Kochel; T C Cheung; G L Yu; S Ruben; M Murphy; R J Eisenberg; G H Cohen; P G Spear; C F Ware
Journal:  Immunity       Date:  1998-01       Impact factor: 31.745

6.  The lymphotoxin-beta receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells.

Authors:  I A Rooney; K D Butrovich; A A Glass; S Borboroglu; C A Benedict; J C Whitbeck; G H Cohen; R J Eisenberg; C F Ware
Journal:  J Biol Chem       Date:  2000-05-12       Impact factor: 5.157

7.  B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator.

Authors:  John R Sedy; Maya Gavrieli; Karen G Potter; Michelle A Hurchla; R Coleman Lindsley; Kai Hildner; Stefanie Scheu; Klaus Pfeffer; Carl F Ware; Theresa L Murphy; Kenneth M Murphy
Journal:  Nat Immunol       Date:  2004-11-28       Impact factor: 25.606

Review 8.  Tumor necrosis factor family ligand-receptor binding.

Authors:  Gongyi Zhang
Journal:  Curr Opin Struct Biol       Date:  2004-04       Impact factor: 6.809

9.  BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1.

Authors:  Norihiko Watanabe; Maya Gavrieli; John R Sedy; Jianfei Yang; Francesca Fallarino; Susan K Loftin; Michelle A Hurchla; Natalie Zimmerman; Julia Sim; Xingxing Zang; Theresa L Murphy; John H Russell; James P Allison; Kenneth M Murphy
Journal:  Nat Immunol       Date:  2003-06-08       Impact factor: 25.606

Review 10.  Viral mimicry of cytokines, chemokines and their receptors.

Authors:  Antonio Alcami
Journal:  Nat Rev Immunol       Date:  2003-01       Impact factor: 53.106
View more
  8 in total

Review 1.  Approaches to studying costimulation of human antiviral T cell responses: prospects for immunotherapeutic vaccines.

Authors:  Lena Serghides; Mariana Vidric; Tania H Watts
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 2.  Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways.

Authors:  Carl F Ware
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

3.  Unconventional ligand activation of herpesvirus entry mediator signals cell survival.

Authors:  Timothy C Cheung; Marcos W Steinberg; Lisa M Oborne; Matthew G Macauley; Satoshi Fukuyama; Hideki Sanjo; Claire D'Souza; Paula S Norris; Klaus Pfeffer; Kenneth M Murphy; Mitchell Kronenberg; Patricia G Spear; Carl F Ware
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-30       Impact factor: 11.205

4.  Selective blockade of herpesvirus entry mediator-B and T lymphocyte attenuator pathway ameliorates acute graft-versus-host reaction.

Authors:  Maria-Luisa del Rio; Nick D Jones; Leo Buhler; Paula Norris; Yasushi Shintani; Carl F Ware; Jose-Ignacio Rodriguez-Barbosa
Journal:  J Immunol       Date:  2012-04-06       Impact factor: 5.422

5.  T cell intrinsic heterodimeric complexes between HVEM and BTLA determine receptivity to the surrounding microenvironment.

Authors:  Timothy C Cheung; Lisa M Oborne; Marcos W Steinberg; Matthew G Macauley; Satoshi Fukuyama; Hideki Sanjo; Claire D'Souza; Paula S Norris; Klaus Pfeffer; Kenneth M Murphy; Mitchell Kronenberg; Patricia G Spear; Carl F Ware
Journal:  J Immunol       Date:  2009-11-13       Impact factor: 5.422

6.  Therapeutic blockade of LIGHT interaction with herpesvirus entry mediator and lymphotoxin β receptor attenuates in vivo cytotoxic allogeneic responses.

Authors:  Maria-Luisa del Rio; Carlos Fernandez-Renedo; Stefanie Scheu; Klaus Pfeffer; Yasushi Shintani; Mitchell Kronenberg; Olivier Chaloin; Pascal Schneider; Jose-Ignacio Rodriguez-Barbosa
Journal:  Transplantation       Date:  2014-12-15       Impact factor: 4.939

7.  IL5RA and TNFRSF6B gene variants are associated with sporadic IgA nephropathy.

Authors:  Xiao-Qing Liu; Andrew D Paterson; Ning He; Peter St George-Hyslop; Virpi Rauta; Carola Gronhagen-Riska; Markku Laakso; Lise Thibaudin; Francois Berthoux; Daniel Cattran; York Pei
Journal:  J Am Soc Nephrol       Date:  2008-02-06       Impact factor: 10.121

8.  Neuron-specific SALM5 limits inflammation in the CNS via its interaction with HVEM.

Authors:  Yuwen Zhu; Sheng Yao; Mathew M Augustine; Haiying Xu; Jun Wang; Jingwei Sun; Megan Broadwater; William Ruff; Liqun Luo; Gefeng Zhu; Koji Tamada; Lieping Chen
Journal:  Sci Adv       Date:  2016-04-08       Impact factor: 14.136
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.